optimal use of tyrosine kinase inhibitors as a treatment for philadelphia chromosome-positive ac...
Published 5 years ago • 91 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
2:58
the neuf study: treatment of r/r philadelphia chromosome-positive all with blinatumomab
-
6:24
targeted therapy for elderly patients with philadelphia-positive acute lymphocytic leukaemia
-
9:14
treating philadelphia chromosome-positive (ph ) all
-
4:20
tyrosine kinase inhibitors (tkis) - imatinib (gleevec) - pharmacology - cml and all
-
5:23
treatment options for ph all
-
6:45
anti-pd1 or tyrosine kinase inhibitors?
-
9:34
optimal use of tkis for therapy of ph-positive all
-
7:32
novel treatment approaches in ph like all
-
8:45
the latest in philadelphia chromosome-positive all (ph all)
-
5:41
tyrosine kinase inhibitor in combination with chemo shows benefit in acute myeloid leukaemia
-
6:01
ponatinib and blinatumomab for patients with philadelphia chromosome-positive all
-
4:57
induction strategies for philadelphia-positive all
-
6:29
philadelphia chromosome-positive all: upfront approaches
-
5:15
blinatumomab and oral tkis for the treatment of ph all
-
2:09
combination of steroids with ponatinib as frontline therapy for acute lymphoblastic leukaemia
-
10:35
update on targeted therapies for philadelphia-like all
-
0:49
exploring novel treatment strategies for ph-like all
-
5:25
bruton tyrosine kinase inhibitors
-
3:45
fda approves use of asciminib for philadelphia chromosome positive chronic myeloid leukaemia